DUAVIVE – tablets for HRT: conjugated estrogens and bazedoxifene, indications and instructions
Ukraine, Dnepr, st. 25 Sicheslavskaya Brigade (Rybinskaya St.), 119 ‑ 120
Ukraine, Dnepr, st. 25 Sicheslavskaya Brigade (Rybinskaya St.), 119 ‑ 120

Treatment of menopause: CONJUGATED ESTROGENS, БАЗЕДОКСИФЕН АЦЕТАТ

Information about medicinal products published on this website is provided for informational purposes only and does not constitute advertising, a public offer, an offer for sale, or instructions for use.
The use of medicinal products is permitted only upon a doctor’s prescription. Consultations are provided by clinic specialists in person or online in accordance with applicable law.

DUAVIVE (ITALY)

Modified-release tablets 0.45 mg + 20 mg
Active ingredients:
• Conjugated estrogens – 0.45 mg
• Bazedoxifene acetate – 20 mg
DUAVIVE (ITALY) | Treatment of menopause
Indications for Use
• Treatment of moderate to severe vasomotor symptoms (hot flashes) in postmenopausal women who require estrogen therapy without the need for progestogen.

Method of Administration and Dosage
• Take 1 tablet once a day, regardless of meals, with a glass of water.
• Do not chew or break the tablet.

Contraindications
• Pregnancy and breastfeeding
• Active phase thromboembolic disorders
• Breast or endometrial cancer
• Severe liver failure
• Not for use in children and adolescents under 18 years of age.

Side Effects
Possible:
• Headache
• Abdominal pain
• Nausea
• Breast pain
• Leg cramps
If side effects occur, consult a doctor.

Special Instructions
• May affect doping test results.
• May interact with other medications, including anticonvulsants and anticoagulants.
• Store at a temperature up to 25°C.

The package contains 28 tablets.
Contact us
Enter your full name.
Enter your phone number.
Choose a convenient messenger to contact you.
Enter a convenient time to contact you.
Enter the essence of the request or your question.
Come back
Request a call back